
Mario Balsa
815 posts

Mario Balsa
@MarioBalsaMD
Galleguiño 🌊 | Medical Oncology resident at @ICO_oncologia | 2025 Rotation Resident Research at @MDAndersonNews 🇺🇸 | @OncoAlert team 💥 | Pianist 🎹









🌐 Big news: The 6th OncoAlert 🚨Colloquium is NOW AVAILABLE IN YOUR LANGUAGE!! 🇪🇸🇮🇳🇵🇹🇮🇹🇫🇷🇺🇦🇯🇵🇲🇽🇸🇦🇷🇺and many more SPOKEN & WITH CAPTIONS in 1⃣8⃣Languages ALL VIDEOS HERE 👇👇oncoalert360.com/multi-language… Top oncology experts. Global reach. Zero barriers. Watch the 50-sec video to learn how #BreastCancer @hoperugo🇺🇸 @matteolambe🇮🇹 @Icro_Meattini🇮🇹 Dr. Roberto Salgado 🇧🇪 @ErikaHamilton9 🇺🇸 @DrSGraff 🇺🇸 @itrisabel🇪🇸 @ESSOnews @ElisaAgostinett 🇧🇪 @RebeccaDSing 🇸🇬 @LazarPo31787807 🇷🇸 #LungCancer @GlopesMd🇺🇸 @jillfeldman4 🇺🇸 @UmbertoMalapel1 🇮🇹 @BRicciutiMD 🇺🇸 @UOzkerim 🇹🇷 @DrMirallas🇺🇸 GU Oncology @brian_rini 🇺🇸 @declangmurphy 🇦🇺 @KidneyCancer🇺🇸 @salvolarosa @Silke_Gillessen🇨🇭 @RenuEapen🇦🇺 @nataliagandur 🇦🇷 @seanmcbride 🇺🇸 @jAvallejo 🇪🇸@GuardConsortium GI Oncology @BenWestphalen 🇩🇪 @graokane 🇮🇪 @GIMedOnc🇺🇸 @NiuSanford 🇺🇸 @ARosen380 🇺🇸 @Erman_Akkus 🇹🇷 @realbowtiedoc 🇺🇸 GynOnc @NicoloBizzarri 🇮🇹Vanda Salutari 🇮🇹 @AStrojnaMD 🇩🇪Alejandra Martinez 🇫🇷 @CoquardRay 🇫🇷Christina Fotopoulou 🇬🇧Giorgia Garganesse 🇮🇹 @ChargariC 🇫🇷 @PaulJiL H&N🇬🇧 @DrJasonWestin Lymphoma🇺🇸 @FadiHaddad_MD Leukemia🇺🇸 @Abdallah81MD Multiple Myeloma🇺🇸 @NassifElise Sarcoma 🇺🇸 @DrBetofMDPhD Melanoma🇺🇸 Our Partners @ESGO_society @ESSOnews @CancerCareMASCC @SIOGorg Our Collaborators @APCCC_Lugano @gu_onc @Uromigos and more and more to come.......







Un estudi del #CampusSalutBellvitge analitza l’ús de tractaments sistèmics en el #cordoma, un tumor ossi molt rar amb alta tendència a la recurrència. Basat en dades de pràctica clínica real, és la sèrie més gran a Europa en aquest àmbit. @MarioBalsaMD ico.gencat.cat/ca/detall/noti…








✨ Nos vemos en el GETNE Campus 2026! Dos días para aprender, debatir y compartir sobre tumores neuroendocrinos y endocrinos. Ciencia, casos clínicos… y mucho espíritu de equipo 🤝 📍 Barcelona | 16–17 abril #GETNECampus #GETNE2026

📣@GgnetGrupo PRRT consensus in NETs is published! ✔️ PRRT for progressive SSTR+ GEP-NETs (G1–G3, Ki-67 ≤55%) 📌 SSTR-PET essential for patient selection 🔎 FDG-PET adds prognostic value 🎯 Practical guidance to harmonize PRRT selection, treatment and follow-up Proud to lead this work! 🔗 doi.org/10.1007/s12094… @OncoAlert













A new study found GLP-1 drugs were associated with 50% fewer substance-related deaths, 39% fewer drug overdoses, and 26% fewer drug-related hospitalizations. trib.al/T2fylNi







